Cargando…
Methods to Make Homogenous Antibody Drug Conjugates
Antibody drug conjugates (ADCs) have progressed from hypothesis to approved therapeutics in less than 30 years, and the technologies available to modify both the antibodies and the cytotoxic drugs are expanding rapidly. For reasons well reviewed previously, the field is trending strongly toward homo...
Autores principales: | Kline, Toni, Steiner, Alexander R., Penta, Kalyani, Sato, Aaron K., Hallam, Trevor J., Yin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596908/ https://www.ncbi.nlm.nih.gov/pubmed/25511917 http://dx.doi.org/10.1007/s11095-014-1596-8 |
Ejemplares similares
-
RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates
por: Yin, Gang, et al.
Publicado: (2017) -
Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
por: Kamath, Amrita V., et al.
Publicado: (2014) -
Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates
por: Jackson, Dowdy, et al.
Publicado: (2014) -
Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001
por: Li, Xiaofan, et al.
Publicado: (2023) -
Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches
por: Hussain, Ahmad Fawzi, et al.
Publicado: (2021)